We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Rationale for Tyrosine Kinase Inhibitors in Non-Advanced Systemic Mastocytosis
Cem Akin, MD, PhD
When Best Supportive Care Is Not Enough: Who Is Eligible for Targeted Therapy in Non-Advanced Systemic Mastocytosis?
Deepti Radia, MD
Assessing Response to Targeted Therapy in Non-Advanced Systemic Mastocytosis: How to Distinguish AEs From Disease Symptoms
Non-CF Bronchiectasis: Navigating the Chronic Cough Vortex
Ashwin Basavaraj, MD
Pamela J. McShane, MD
Colin Swenson, MD
Gregory Tino, MD
Jungae Kole, RN, BSN
Non-CF Bronchiectasis (NCFBE): Redefined
Non-CF Bronchiectasis (NCFBE): Identifying At-Risk Patients
The Neutrophil and Neutrophil Serine Proteases (NSPs) in Non-CF Bronchiectasis (NCFBE)
Vortex Management: Diagnostic Algorithm for the PCP and Specialist
Vortex Management: Multiprong and Individualized Treatment Approach
Caregiver Perspective: A Day in the Life of the Bronchiectasis Patient
Caregiver Testimonial: A Day in the Life of the Bronchiectasis Patient
The When and How of Implementing New Anti-Neutrophil Therapies Into Standard Clinical Practice
Advancing Diagnosis and Risk Assessment in PH
Richard N. Channick, MD
Jean M. Elwing, MD
Dinesh Khanna, MD, MS
Martha Kingman, DNP, FNP-C
Richard Krasuski, MD
Vallerie V. McLaughlin, MD
Sudarshan Rajagopal, MD, PhD
Rajan Saggar, MD
Oksana A. Shlobin, MD
Will Lowering the Hemodynamic Threshold for PH Impact “Discovery” of New Patients?
Diagnosing PAH: New Emphases on Imaging Modalities
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education